Editorial Board for section 'Hepatitis Virus Vaccines'

Please see the section webpage for more information on this section.

Please note that the order in which the Editors appear on this page is alphabetical, and follows the structure of the editorial board presented on the MDPI website under information for editors: editorial board responsibilities.


Section Editor-in-Chief
Associate Professor, Infectious Diseases Translational Research Programme and Department of Microbiology and Immunology, Yong Loo Lin School of Medicine, National University of Singapore, Singapore
Interests: characterization of newly emerged viruses and hepatitis viruses; development of antibodies for diagnostic and therapeutic applications; protein engineering
* Section: Hepatitis Virus Vaccines
Special Issues, Collections and Topics in MDPI journals

Section Board Member
Vancouver Infectious Diseases Centre, Vancouver, BC V6Z 2C7, Canada
Interests: HIV infection; HCV infection; inner city medicine
The Institute for Medical Virology, Justus Liebig University, 35392 Giessen, Germany (Retired)
Interests: hepatitis B virus; viral hepatitis; hepadnaviruses; vaccines; antiviral therapy; viral diagnosis; immune assays

Section Board Member
1. Division of Veterinary Medicine, Paul Ehrlich Institute, Langen, Germany
2. European Virus Bioinformatics Center (EVBC), Jena, Germany
Interests: coronavirus; SARS-CoV-2; variant of concern; vaccine evaluation; T Lymphocytes; HBV
Special Issues, Collections and Topics in MDPI journals
Dr. Carlo Saitta
Section Board Member
1. Division of Medicine and Hepatology, University Hospital of Messina, 98124 Messina, Italy
2. Department of Clinical and Experimental Medicine, University of Messina, 98124 Messina, Italy
Interests: hepatocellular carcinoma; viral hepatitis; HBV; HCV; non-alcoholic steatohepatitis; liver steatosis; cholangiocarcinoma; primary biliary cholangitis; liver cirrhosis; portal hypertension.
Dr. Ryosuke Suzuki

Section Board Member
Department of Virology II, National Institute of Infectious Diseases, Tokyo 162-0052, Japan
Interests: hepatitis viruses; flaviviruses; reverse genetics; vaccine; neutralizing antibody
Back to TopTop